References
- D. C. Duvoisin. Antagonism of levodopa by papaverine. JAMA 1975; 231(8)895
- Ferrari M. Effects of papaverine on smooth muscle and their mechanisms. Pharm. Res. Commun. 1974; 6(2)97
- Urban J., Czekanowski R. Influence of adrenergic alpha-receptors blockage on the activity of preparations stimulating and inhibiting rat uterine contractility. Ginekol. Pol. 1969; 40(10)1093
- Szekeras L., GyPapp J., Fischer E. The possible role of an adrenergic mechanism in the antianginal action of papaverine and prenylamine. Europ. J. Pharmacol. 1967; 2(1)1
- Duchene-Marullaz P., Schaff G., Lautier F., Lavarenne J. Positive chronotropic effect of papaverine: changes induced by propranolol. Compt. Rend. Soc. Biol. 1967; 161(2)318
- Holtz P., Stock K., Westermann E. Pharmakologie des tetrahydropapaverolins und seine entstehung aus dopamin. Naunyn-Schmiedeberg's Arch. Exptl. Pathol. Pharmakol. 1964; 248: 387
- Holtz P., Langeneckert W., Palm D. Sympathomimetic actions of papaverine derivatives, Naunyn-Schmiedeberg's. Arch. Exptl. Pathol. Pharmakol. 1968; 259(3)290
- Zarlengo D., Hansl N. R. On the nature of the spasmolytic action of papaverine. Proc. Nebr. Acad. Sci. 1975
- Farmer J. B., Chick E. A. Bronchodilator actions of papaverine in the anaesthetized guinea-pig. J. Pharm. Pharmac. 1967; 19: 124
- Santi R., Ferrari M., Toth C. E., Contessa A. R., Fassina G., Bruni A., Luciani S. Pharmacological properties of tetrahydropapaveroline. J. Pharm. Pharmacol. 1967; 19: 45
- Levy B., Ahlquist R. P. An analysis of adrenergic blocking activity. J. Pharm. Exptl. Therap. 1961; 132–133: 202
- Kohli J. D., Ling G. M. Alpha adrenergic blocking action of propranolol. J. Pharm. Pharmacol. 1967; 19: 629
- Levy J. V. Positive inotropic effects of papaverine and aminophylline on isolated human atrial preparations. Res. Commun. Chem. Pathol. Pharmacol. 1972; 4(2)261